首页> 外国专利> INTRANASAL INSULIN ADMINISTRATION FOR THE PREVENTION OF ANESTHESIA-INDUCED TAU PATHOLOGY/TAUOPATHIES

INTRANASAL INSULIN ADMINISTRATION FOR THE PREVENTION OF ANESTHESIA-INDUCED TAU PATHOLOGY/TAUOPATHIES

机译:鼻内胰岛素管理以预防麻醉引起的TAU病理学/ TAUOPATHIES

摘要

Intranasal administration of insulin for a predetermined period prior to anesthesia significantly prevented anesthesia-induced tau hyperphosphorylation and cognitive impairment and enhanced brain insulin signaling in mice. Intranasal insulin thus provides a treatment for prevention of anesthesia-induced tau pathology and increased risk for tauopathies in surgical patients and may be administered to a subject prior to anesthesia, such as by administering several doses of intranasal insulin for several consecutive days prior to any anesthesia.
机译:在麻醉前的预定时间内对胰岛素进行鼻内给药可显着防止麻醉引起的tau过度磷酸化和认知障碍,并增强小鼠的脑胰岛素信号传导。鼻内胰岛素因此提供了用于预防手术患者中麻醉引起的tau病理学和增加口疮的风险的治疗,并且可以在麻醉之前向受试者施用,例如通过在任何麻醉之前连续几天施用几剂鼻内胰岛素。 。

著录项

  • 公开/公告号US2015258178A1

    专利类型

  • 公开/公告日2015-09-17

    原文格式PDF

  • 申请/专利权人 THE RESEARCH FOUNDATION FOR MENTAL HYGIENE INC.;

    申请/专利号US201514656975

  • 发明设计人 CHENG-XIN GONG;

    申请日2015-03-13

  • 分类号A61K38/28;

  • 国家 US

  • 入库时间 2022-08-21 15:27:15

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号